Gitnux/Report 2026

Bio Foundation Models Industry Statistics

The industry counted about 1,100 biologic foundation models in 2025, explore the figures behind growth to 5,900 by 2028, plus company activity and benchmark constraints.
4Statistics
24Sources
1Sections
1Visuals
11mRead
Bio Foundation Models Industry Statistics
How this report is researched
01Editorial Scope

Gitnux editors write the brief first: the topic, the inclusion rules, and the frame for what belongs.

02Source Research

Agents search the published record and log every extracted figure back to the passage it came from.

Read our full methodology →

Search agents attach provenance to every extracted figure.

Next review: within 28 days

01 Industry overview

The bio foundation models industry at a glance

Bio foundation models are scaling rapidly: William Blair estimates about 1,100 models existed in 2025, while leading systems such as Evo 2 reached 40 billion parameters and trained on 9.3 trillion DNA base pairs.

~1,100[3]
Biologic models in 2025
40B[4]
Evo 2 parameters in 2025
9.3T[4]
DNA base pairs for Evo 2
500+[5]
AI submissions reviewed since 2016
Forecast & CAGR
A conventional revenue estimate for the bio foundation models industry was not available from a sufficiently reliable primary or established industry source. William Blair instead forecasts the number of biologic foundation models rising from about 1,100 in 2025 to about 5,900 in 2028, implying roughly 75% annualized growth in model count over the period.[3]
Segmentation
The industry is commonly divided into protein-centric models and cell-state or perturbation-response models. Protein models support hit and lead design and optimization, while cell-state models are used heavily for target discovery and validation; the 2025 landscape also included genomic, cellular, neuroscience, and proteomics models.[3][4]
Trends, drivers & challenges
Scale is being driven by larger biological datasets, compute and laboratory feedback loops. In 2025, Evo 2 used 9.3 trillion DNA base pairs and up to 40 billion parameters, but performance remains constrained by workflow reliability: BixBench reported roughly 17% accuracy for frontier models on real-world bioinformatics tasks, and BioML-bench found agents underperformed human baselines on average.[4][6]
Consumer behavior & competition
Competition is shifting from standalone model releases toward integrated, lab-in-the-loop platforms. Amazon Web Services said its 2026 Bio Discovery service combined more than 40 AI biology models and could narrow 300,000 antibody candidates to leading candidates for testing, while the broader benchmark evidence shows that models still struggle with multistep biological workflows.[7][4]
Regulation
The FDA’s January 2025 draft framework uses a risk-based approach for establishing the credibility of AI models used in drug and biological-product submissions. The agency said it had experience with more than 500 drug and biological-product submissions containing AI components since 2016 and emphasized defining a model’s context of use.[5]
Latest news
In October 2026, Zuckerberg’s Biohub announced a partnership with Google and the U.S. government to generate biological data for models that predict cellular behavior. The initiative was reported at $1.8 billion in combined funding, data, computing and measurement technology, including more than $500 million planned from the U.S. Department of Energy and $300 million from Google DeepMind, Isomorphic Labs and Meta.[6]

02 Ranking

Top 10 Companies in the Bio Foundation Models Industry

The leading companies in the bio foundation models industry, ranked on market impact, performance, momentum, innovation and brand popularity.

Updated November 20, 2026 · Next review December 20, 2026

Verdict

Nvidia stands out for BioNeMo drug-discovery and protein-engineering foundation models because it reported an operating margin of 60.38% with R&D at 8.57% of revenue, while DeepMind focuses on protein structure prediction since it created AlphaFold.

Ranked by Overall score · How we score ↓

Editor's top 3 picks

Where to start, by need.

  1. #1 Overall · Leader in drug design models

    Nvidia

    US

    Ranked #1 · 9.5 · Drug design models

    Why we picked it: It operates BioNeMo and reported an operating margin of 60.38% with R&D at 8.57% of revenue.

  2. Leader in protein structure prediction

    DeepMind

    GB

    Ranked #2 · 9.3 · Protein structure prediction

    Why we picked it: It created AlphaFold, and in financials it reported an operating margin of 32% and R&D at 15.2% of revenue.

  3. Leader in antibody design models

    Chai Discovery

    US

    Ranked #4 · 8.9 · Antibody design models

    Why we picked it: It provides antibody design via Chai-2 aimed at challenging molecular targets.

Pick 1 is the #1 company overall. Picks 2 and 3 are the highest-ranked companies in the top 5 that add a new segment.

Full ranking

Sort by
Top 10 companies in the bio foundation models industry, 2026 – Gitnux ranking
#CompanyOverall ↓Company snapshot
1

Nvidia

Drug design models · US

9.5
2

DeepMind

Protein structure prediction · GB

9.3
3

Isomorphic Labs

Drug design models · GB

9.2
4

Chai Discovery

Antibody design models · US

8.9
5

Generate Biomedicines

Protein molecule generation · US

8.9
6

Insilico Medicine

Generative AI drug discovery platform and models · US

8.7
7

Owkin

Biological reasoning and pathology foundation models · US

8.6
8

BioMap

Multimodal life-science foundation models

8.2
9

Profluent

Protein language models and generative protein design · US

8.2
10

EvolutionaryScale

ESM protein language models, US · US

7.4

How we score

  • Impact (30%): scale and weight in the market (revenue, market share, employees, market position).
  • Performance (20%): recent revenue growth and operating margin; an analyst assessment where a company does not publish them.
  • Momentum (20%): growth trajectory and future potential.
  • Innovation (15%): R&D intensity and how technologically advanced the company is.

Popularity (brand search demand, 15%) counts toward Overall but is not published as a column. Overall leaves out what is not known.

Scale Scores are shown on a 7–10 scale with one decimal; bars start at 7.0.

Cadence Recalculated when new figures are published; next review December 20, 2026.

Independence. Rankings are editorially independent. Scores, ranks, picks and the verdict follow the method above; no company can pay to change them.

Cite this ranking

APA

Samuel Norberg. (2026, November 20). Top 10 companies in the bio foundation models industry. In Bio Foundation Models Industry Statistics. Gitnux. https://gitnux.org/bio-foundation-models-industry-statistics/#top-companies

report visual · Comparison

AI-for-pharma vendors by offering type

Workflow tool holds the largest share at 96.

Workflow tool96
Predictive model38
Services (CRO, lab, consulting)33
Data29
Hardware / automation12
AI infrastructure5
source-verifiedelicit.com

04 Statistics

Market Intelligence

The November 6, 2026 catalog lists 538 biological foundation models and resources, including 204 with open code and weights.

Product counts and provider structure in the bio foundation models industry

  • 204 of 538 catalogued biological foundation models and resources had open code and weights in the November 6, 2026 update.[1]
  • 538 biological foundation models and resources were catalogued worldwide in the November 6, 2026 update, including models for sequences, molecules, structures, omics, cells and tissue images.[1]
  • 220 unique biomedical foundation models were identified across natural language, imaging and signals, omics, and molecular-sequence fields in a survey covering the previous four years.[2]
  • 118 of 220 surveyed biomedical foundation models, or 53.6%, integrated two or more modalities across 17 biological data modalities.[2]

Key questions about the bio foundation models industry

How many biologic foundation models existed in 2025?
About 1,100 biologic foundation models existed in 2025, based on William Blair’s estimate.
What does the industry growth outlook look like for model counts?
William Blair forecasts model count rising from about 1,100 in 2025 to about 5,900 in 2028, implying roughly 75% annualized growth in model count.
Which companies lead the bio foundation models industry?
Nvidia stands out for BioNeMo drug-discovery and protein-engineering foundation models because it reported an operating margin of 60.38% with R&D at 8.57% of revenue, while DeepMind focuses on protein structure prediction since it created AlphaFold.
What technology shift is driving integration and lab-in-the-loop work?
Competition is shifting from standalone model releases toward integrated, lab-in-the-loop platforms, reflecting scale driven by larger biological datasets, compute, and laboratory feedback loops.
How is the bio foundation models market typically structured by model type?
The industry is commonly divided into protein-centric models and cell-state or perturbation-response models, with protein models supporting hit and lead design and cell-state models used for target discovery and validation.
What constraint shows up most often in real-world workflow performance?
Workflow reliability remains constrained: BixBench reported roughly 17% accuracy for frontier models on real-world bioinformatics tasks.
Reference

Cite This Report

This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.

APA
Samuel Norberg. (2026, November 20). Bio Foundation Models Industry Statistics. Gitnux. https://gitnux.org/bio-foundation-models-industry-statistics
MLA
Samuel Norberg. "Bio Foundation Models Industry Statistics." Gitnux, 20 Nov 2026, https://gitnux.org/bio-foundation-models-industry-statistics.
Chicago
Samuel Norberg. 2026. "Bio Foundation Models Industry Statistics." Gitnux. https://gitnux.org/bio-foundation-models-industry-statistics.